Lilly admits paying docs to peddle drugs – at what cost??

As part of a large government fine of $1.4 BILLION Eli Lilly, makers of Prozac, Cymbalta, Stratera, Cialis, etc. has begun to disclose payouts to doctors to peddle their wares/drugs. When you consider the long reaching damaging effects of that, you realize that the fine is nothing compared to the loss of lives that are the end result.
Let’s look at just a few facts:
1. The third leading cause of death in America is “properly prescribed (following FDA and AMA guidelines) prescription drugs. That does not count those taking these drugs “off label” or in higher amounts than recommended, etc., but only taking them as recommended by those who are suppose to know safest prescribing guidelines.

Eli Lilly and Co. paid Jacksonville-area doctors thousands of dollars as consultants to market drugs

Maker of Prozac and Cialis was forced to publish doctor names and compensation.

  • Story updated at 11:29 PM on Friday, Sep. 4, 2009

Drug companies routinely pay physicians as experts in the course of marketing their products. While legal, the practice is widely criticized as a conflict of interest that drives up drug costs.

One pharmaceutical company paid more than $76,000 to Jacksonville-area doctors and other medical providers in the first three months of this year.

That’s according to the first publicly released information to document the long-hidden financial ties between drug companies and doctors.

Eli Lilly and Co., the maker of Prozac, Cymbalta and Cialis, was forced to begin publishing the names and compensation of its paid consultants as part of a $1.4 billion settlement with the federal government last January.

Among the names that became public were those of several physicians practicing in the Jacksonville area. For the full story, including names of the physicians, see Sunday’s Business section of the Times-Union.


Wendell's picture

Dr.’s are as bad as politicians!

Submitted by Wendell on Fri. 9/4/2009 at 5:09 pmDr.’s are as bad as politicians!

  • Login or register to post comments
  • Flag as offensive
  • Dr’s Got To Make A Living Too

    Submitted by fearlessfan on Fri. 9/4/2009 at 9:05 pmYou shouldn’t blame the doctors, it’s the high dollar Pharmaceutical companies who are pushing the dough.   Anybody in their right mind would take it especially if its legal; too heck with ethics.

  • Login or register to post comments
  • Flag as offensive
  • It is all about ethics

    Submitted by rs471911 on Sat. 9/5/2009 at 10:50 am Recently I was in my doctor’s waiting room, 45 minutes past my scheduled appointment. During my wait I watched as 4 pharmaceutical reps, one after another, walked right in to see the doctor and peddle their drugs. The nurse said the doctor sees each rep personally. When I finally saw the doctor I asked if he saw more pharmaceutical reps or patients a day. He gets perks for prescribing their drugs. The scariest part was I heard him asking one of the reps for medical advice. He is no longer my doctor.

  • Login or register to post comments
  • Flag as offensive
  • I had the same thing happen to me six years ago///

    Submitted by Xenon on Sat. 9/5/2009 at 1:53 pmI also was waiting for a appointment for over 45 minutes and was shocked at the people walking in and out without signing in. Finally when i was checking out, three representatives were in the hallway laughing and talking with the Doctor and talking about a upcoming quail hunt, Montana hunting trip and a deep sea fishing trip at their expense, one female representative turned to me and handled me a pen, with pharmaceutical advertisement on it as i was trying to sign my check and said to me, “Just keep it, a sovernier.” Smiled perkily and turned back to the group and the Doctor.

    I have not been back since. I just wish integrity, honor, honesty and accountability would come back along with true patriotism for our country and it’s citizens. My age is showing…

  • Login or register to post comments
  • Flag as offensive
  • 1,320 total views, no views today

    4/17/2001 – Snub to Prozac critic upsets teachers

    Snub to Prozac critic upsets teachers

    Faculty group sees academic freedom
    at risk in U of T withdrawal of job offer

    Monday, April 16, 2001

    The Canadian Association of University Teachers says it is disturbed by the
    University of Toronto’s decision to revoke the job offer it made to an
    internationally recognized psychiatrist after he criticized a drug company.

    “It appears that there has been a very serious violation of academic freedom
    at the University of Toronto that requires remedy,” James Turk, executive
    director of the association, said in a letter to U of T president Robert

    The U of T and the Centre for Addiction and Mental Health, an affiliated
    teaching hospital, had been courting Dr. David Healy since July of 1999. He
    is an expert in drugs and psychiatry at the University of Wales.

    They made him a formal, written offer of a combined faculty and clinical
    position in May of 2000, and sent a more detailed letter in August. The U of
    T hired a lawyer to help him immigrate.

    Then, on Nov. 30, 2000, Dr. Healy gave a lecture at the CAMH in which he
    criticized drug companies for avoiding experiments that may show there are
    problems with their drugs, and for not publishing unfavourable results. He
    said the data show that Prozac, manufactured by Eli Lilly and Co., may cause
    suicide in some people.

    Eli Lilly is the “lead” donor to the CAMH, according to its Web site, and has
    contributed more than $1-million to the centre’s $10-million capital
    campaign. It argues Prozac is safe.

    Last year, Eli Lilly cancelled its $25,000 (U.S.) annual donation to the
    Hastings Center in New York, a think tank that looks at ethical issues, after
    it published a series of articles about Prozac, including a critical one by
    Dr. Healy.

    “There are good grounds to believe that Prozac can trigger suicidality. The
    pharmaceutical companies are not investigating, however; one wonders whether
    they are receiving legal advice echoing that given to the tobacco companies,
    that any investigation of these issues may increase product liability,” Dr.
    Healy wrote.

    Eli Lilly says it withdrew funding because the Hastings Center published
    “articles which Lilly felt contained information that was biased and
    scientifically unfounded, and that may have led to significant misinformation
    to readers, patients and the community,” said Laurel Swartz, manager of
    corporate communications for Eli Lilly.

    A week after Dr. Healy’s speech, Dr. David Goldbloom, physician-in-chief at
    the CAMH and a professor at the U of T, rescinded his job offer.

    The CAMH says the decision was made on the basis of a number of factors it
    can’t make public. Eli Lilly says it played no role.

    Mr. Turk has asked for a meeting with the U of T president to discuss what

    David Naylor, dean of the University of Toronto’s faculty of medicine, says
    it is not the U of T’s role to launch an inquiry.

    The eight hospitals affiliated with the U of T are responsible for their own
    human-resources decisions, he said. In the case of Dr. Healy, the CAMH would
    have been the primary employer, not the U of T.

    Yet it was the U of T vice-provost who sent Dr. Healy a memo confirming his
    offer of employment and informing him that a lawyer had been hired to help
    him immigrate.

    While saying that the Dr. Healy affair is strictly in the domain of the CAMH,
    Dr. Naylor acknowledges that he did make inquiries about what happened.

    “I don’t believe there is any particular conspiracy, conflict of interest or
    any malice here. In fact, I am satisfied there is not.”

    864 total views, no views today